Cargando…

Antiretroviral Treatment-Induced Decrease in Immune Activation Contributes to Reduced Susceptibility to Tuberculosis in HIV-1/Mtb Co-infected Persons

Antiretroviral treatment (ART) reduces the risk of developing active tuberculosis (TB) in HIV-1 co-infected persons. In order to understand host immune responses during ART in the context of Mycobacterium tuberculosis (Mtb) sensitization, we performed RNAseq analysis of whole blood-derived RNA from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilkinson, Katalin A., Schneider-Luftman, Deborah, Lai, Rachel, Barrington, Christopher, Jhilmeet, Nishtha, Lowe, David M., Kelly, Gavin, Wilkinson, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973093/ https://www.ncbi.nlm.nih.gov/pubmed/33746987 http://dx.doi.org/10.3389/fimmu.2021.645446

Ejemplares similares

Tuberculosis Antigen-Specific T-Cell Responses During the First 6 Months of Antiretroviral Treatment
por: Riou, Catherine, et al.
Publicado: (2020)

The effect of antiretroviral treatment on selected genes in whole blood from HIV-infected adults sensitised by Mycobacterium tuberculosis
por: Jhilmeet, Nishtha, et al.
Publicado: (2018)

Invariant Natural Killer T-cell Dynamics in Human Immunodeficiency Virus–associated Tuberculosis
por: Walker, Naomi F, et al.
Publicado: (2020)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial
por: Mupfumi, L., et al.
Publicado: (2014)

The Mtb-HIV syndemic interaction: why treating M. tuberculosis infection may be crucial for HIV-1 eradication
por: Waters, Robyn, et al.
Publicado: (2020)

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)

The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia
por: Diriba, Kuma, et al.
Publicado: (2021)

Detection of Mycobacterium tuberculosis (MTB) in Fecal Specimens From Adults Diagnosed With Pulmonary Tuberculosis Using the Xpert MTB/Rifampicin Test
por: Kokuto, Hiroyuki, et al.
Publicado: (2015)

Ability of the MeltPro MTB/PZA Assay to Detect Susceptibility to Pyrazinamide in Rifampin-Resistant Tuberculosis Patients
por: Li, Rong, et al.
Publicado: (2023)

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020)

Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF
por: Singh, Urvashi B., et al.
Publicado: (2023)

Characteristics and Early Outcomes of Patients With Xpert MTB/RIF-Negative Pulmonary Tuberculosis Diagnosed During Screening Before Antiretroviral Therapy
por: Lawn, Stephen D., et al.
Publicado: (2012)

Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases
por: Vadwai, Viral, et al.
Publicado: (2012)

Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection model
por: Harrington-Kandt, Rachel, et al.
Publicado: (2018)

Evaluation of Xpert(®) MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

MTB-PCDB: Mycobacterium tuberculosis proteome comparison database
por: Jena, Lingaraja, et al.
Publicado: (2011)

FluoroType MTB system for the detection of pulmonary tuberculosis
por: Obasanya, Joshua, et al.
Publicado: (2017)

Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis
por: Li, Hou-He, et al.
Publicado: (2020)

Brief Report: HIV-1 Infection Impairs CD16 and CD35 Mediated Opsonophagocytosis of Mycobacterium tuberculosis by Human Neutrophils
por: Bangani, Nonzwakazi, et al.
Publicado: (2016)

Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study
por: Lawn, Stephen D., et al.
Publicado: (2011)

Smoking, BCG and Employment and the Risk of Tuberculosis Infection in HIV-Infected Persons in South Africa
por: Oni, Tolu, et al.
Publicado: (2012)

Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia
por: Stagg, Helen R., et al.
Publicado: (2016)

Targeting Unconventional T Cells for Vaccination against Tuberculosis
por: Wilkinson, Katalin A., et al.
Publicado: (2020)

Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey
por: Dorman, Susan E., et al.
Publicado: (2012)

Phenotypic drug susceptibility characterization and clinical outcomes of tuberculosis strains with A-probe mutation by GeneXpert MTB/RIF
por: Nie, Qi, et al.
Publicado: (2023)

Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study
por: Wasihun, Araya Gebreyesus, et al.
Publicado: (2020)

Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
por: Kohli, Mikashmi, et al.
Publicado: (2018)

Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis
por: Antel, Katherine, et al.
Publicado: (2020)

Detection of Mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and GeneXpert(®) MTB/RIF assay
por: Rasool, Ghulam, et al.
Publicado: (2019)

Inflammasome Activation Underlying Central Nervous System Deterioration in HIV-Associated Tuberculosis
por: Marais, Suzaan, et al.
Publicado: (2017)

High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening
por: Oni, Tolu, et al.
Publicado: (2011)

Differential Effect of Viable Versus Necrotic Neutrophils on Mycobacterium tuberculosis Growth and Cytokine Induction in Whole Blood
por: Lowe, David M., et al.
Publicado: (2018)

Tuberculosis infection and disease in South African adolescents with perinatally acquired HIV on antiretroviral therapy: a cohort study
por: Frigati, Lisa J, et al.
Publicado: (2021)

Effect of prednisolone on inflammatory markers in pericardial tuberculosis: A pilot study
por: Shenje, Justin, et al.
Publicado: (2017)

Diagnostic Accuracy of the Truenat MTB Plus Assay and Comparison with the Xpert MTB/RIF Assay to Detect Tuberculosis among Hospital Outpatients in Cameroon
por: Ngangue, Yannick Russel, et al.
Publicado: (2022)

Evaluation of Xpert MTB/RIF Assay, MTB Culture and Line Probe Assay for the Detection of MDR Tuberculosis in AFB Smear Negative Specimens
por: Lama, Chandri, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8kg7fou7rsfdl5likvjk4qh43l